Ultra-high-field MRI may allow earlier diagnosis of Parkinson's disease
New research shows that ultra-high-field magnetic resonance imaging (MRI) provides detailed views of a brain area implicated in Parkinson's disease, possibly leading to earlier detection of a condition that affects millions worldwide. The results of this research are published online in the journal Radiology.
Parkinson's disease is a chronic, progressive disease characterized by shaking, stiffness, and impaired balance and coordination. With no radiologic techniques available to aid in diagnosis, clinicians have had to rely on medical history and neurological examination. It is often difficult to distinguish Parkinson's disease from other conditions using these methods alone.
Mirco Cosottini, M.D., from the University of Pisa in Italy, and colleagues studied the brains of 38 individuals, including 17 Parkinson's disease patients and 21 healthy controls, as well as a brain specimen from a deceased individual, to help determine the accuracy of ultra-high-field 7-Tesla (7-T) MRI for identifying Parkinson's disease.
Using the 7-T MRI, the researchers were able to distinguish a three-layered organization of the substantia nigra (SN), a crescent-shaped mass of cells in the midbrain. Parkinson's disease results from the loss of dopamine-producing cells located in this region of the brain. Dopamine is an important neurotransmitter involved in multiple brain functions, including motor and behavioral processes such as mood, reward, addiction and stress.
Based on abnormalities in the SN identified by the 7-T MRI, the researchers correctly classified patients with Parkinson's disease with a sensitivity of 100 percent and specificity of 96.2 percent.
According to Dr. Cosottini, the results show promise for earlier detection of the disease, which could speed the initiation of treatment.
"Parkinson's disease diagnosis remains clinically based, but with the introduction of 7-T MRI into clinical practice, a supporting radiologic diagnosis can be made," he said.
The researchers also are exploring the clinical utility of 7-T MRI in several other neurodegenerative diseases, including mild cognitive impairment, a precursor of Alzheimer's disease.
More information: "MR Imaging of the Substantia Nigra at 7 T Enables Diagnosis of Parkinson Disease." Radiology, 2014.
A genetic mutation, known as GBA, that leads to early onset of Parkinson's disease and severe cognitive impairment (in about 4 to 7 percent of all patients with the disease) also alters how specific lipids, ceramides and ...
A new triple gene therapy called ProSavin might safely improve motor function in Parkinson's patients by reprogramming brain cells to produce dopamine—a chemical essential for the proper control of movement—according ...
A new iPhone mobile app which allows patients with Parkinson's disease to track their symptoms in real time and share this information with researchers was featured by Apple executives today during the company's ...
Although levodopa remains the "gold standard" to effectively control motor deficits in the treatment of early stage Parkinson's disease (PD), it loses effectiveness as the disease progresses. After four to six years of treatment ...
Patients with Parkinson's disease (PD) often have difficulties with visual acuity in low-contrast images. Because they may have normal high-contrast vision, this is often overlooked during routine eye exams. In the current ...
Parkinson's disease is the second neurodegenerative disease in number of patients after Alzheimer's disease. The Technical Research Centre for Dependency Care and Autonomous Living (CETpD) of the Universitat ...
Please sign in to add a comment.
Registration is free, and takes less than a minute.
Click here to reset your password.
Sign in to get notified via email when new comments are made.